This conversation was recorded in May 2020, but felt the lessons and takeaways are still very relevant as we are finally starting to emerge from the COVID-19 pandemic. The rates of depression, suicide, and substance use are expected to ...
COVID-19 has elevated our nation’s stress level. When not managed properly (or without any buffers like social support) stress is associated with increased depression and anxiety. Because COVID-19 impacts risk factors for suicide, such as ...
In the United States, suicide and overdose are among the top 10 leading causes of death. At the intersection of suicide and overdose are shared factors that can be assessed to support a comprehensive approach to prevention. The COVID-19 ...
State and territorial health leaders are thinking long-term about how policy changes made as a response to the pandemic might be continued to support vulnerable populations. During this episode, public health experts discuss how states and ...
In 2020, the COVID-19 pandemic exacerbated barriers to care and treatment for individuals experiencing opioid use disorder. Experts estimate a record-setting 90,000 people died of a drug overdose in 2020. Additionally, as the pandemic ...
With data showing the number of the opioid overdose deaths escalated during the COVID-19 pandemic, access to naloxone, a medication that can reverse an opioid overdose, continues to be an important topic for policy makers. The number of ...
October is Domestic Violence Awareness Month, a critical moment to address intimate partner violence as a major public health threat. Intimate partner violence associated with substance use disorders and mental health challenges, and ...